Report Detail

Pharma & Healthcare Global PEGylated Proteins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3144934
  • |
  • 19 March, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.

Scope of the Report:
The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturers and suppliers lose their bargaining power. Consumers are able to purchase competitor's products if they are not satisfied with product price or quality. In order for suppliers to tackle the challenge of threat of substitutes, they have to innovate products which meet the needs of their target market segments.
The worldwide market for PEGylated Proteins is expected to grow at a CAGR of roughly 3.9% over the next five years, will reach 3910 million US$ in 2024, from 3230 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the PEGylated Proteins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor Viii
Monoclonal Antibodies
Others

Market Segment by Applications, can be divided into
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PEGylated Proteins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PEGylated Proteins, with price, sales, revenue and global market share of PEGylated Proteins in 2017 and 2018.
Chapter 3, the PEGylated Proteins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PEGylated Proteins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, PEGylated Proteins market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe PEGylated Proteins sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 PEGylated Proteins Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Colony Stimulating Factors
      • 1.2.2 Interferons
      • 1.2.3 Erythropoietin (EPO)
      • 1.2.4 Recombinant Factor Viii
      • 1.2.5 Monoclonal Antibodies
      • 1.2.6 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Cancer Treatment
      • 1.3.2 Hepatitis
      • 1.3.3 Chronic Kidney Disease
      • 1.3.4 Leukemia
      • 1.3.5 SCID
      • 1.3.6 Rheumatoid Arthritis & Crohn's Disease
      • 1.3.7 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 ENZON Pharmaceuticals
      • 2.1.1 Business Overview
      • 2.1.2 PEGylated Proteins Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Merck Sharp & Dohme
      • 2.2.1 Business Overview
      • 2.2.2 PEGylated Proteins Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Roche
      • 2.3.1 Business Overview
      • 2.3.2 PEGylated Proteins Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Roche PEGylated Proteins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Pfizer
      • 2.4.1 Business Overview
      • 2.4.2 PEGylated Proteins Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Pfizer PEGylated Proteins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Amgen
      • 2.5.1 Business Overview
      • 2.5.2 PEGylated Proteins Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Amgen PEGylated Proteins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 UCB
      • 2.6.1 Business Overview
      • 2.6.2 PEGylated Proteins Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 UCB PEGylated Proteins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Crealta (Savient)
      • 2.7.1 Business Overview
      • 2.7.2 PEGylated Proteins Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Crealta (Savient) PEGylated Proteins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global PEGylated Proteins Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global PEGylated Proteins Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global PEGylated Proteins Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 PEGylated Proteins Manufacturer Market Share in 2018
      • 3.3.2 Top 6 PEGylated Proteins Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global PEGylated Proteins Market Analysis by Regions

    • 4.1 Global PEGylated Proteins Sales, Revenue and Market Share by Regions
      • 4.1.1 Global PEGylated Proteins Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global PEGylated Proteins Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 4.3 Europe PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 4.5 South America PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa PEGylated Proteins Sales and Growth Rate (2014-2019)

    5 North America PEGylated Proteins by Country

    • 5.1 North America PEGylated Proteins Sales, Revenue and Market Share by Country
      • 5.1.1 North America PEGylated Proteins Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America PEGylated Proteins Revenue and Market Share by Country (2014-2019)
    • 5.2 United States PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 5.3 Canada PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 5.4 Mexico PEGylated Proteins Sales and Growth Rate (2014-2019)

    6 Europe PEGylated Proteins by Country

    • 6.1 Europe PEGylated Proteins Sales, Revenue and Market Share by Country
      • 6.1.1 Europe PEGylated Proteins Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe PEGylated Proteins Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 6.3 UK PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 6.4 France PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 6.5 Russia PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 6.6 Italy PEGylated Proteins Sales and Growth Rate (2014-2019)

    7 Asia-Pacific PEGylated Proteins by Country

    • 7.1 Asia-Pacific PEGylated Proteins Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific PEGylated Proteins Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific PEGylated Proteins Revenue and Market Share by Country (2014-2019)
    • 7.2 China PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 7.3 Japan PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 7.4 Korea PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 7.5 India PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia PEGylated Proteins Sales and Growth Rate (2014-2019)

    8 South America PEGylated Proteins by Country

    • 8.1 South America PEGylated Proteins Sales, Revenue and Market Share by Country
      • 8.1.1 South America PEGylated Proteins Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America PEGylated Proteins Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 8.3 Argentina PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 8.4 Colombia PEGylated Proteins Sales and Growth Rate (2014-2019)

    9 Middle East and Africa PEGylated Proteins by Countries

    • 9.1 Middle East and Africa PEGylated Proteins Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa PEGylated Proteins Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa PEGylated Proteins Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 9.3 Turkey PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 9.4 Egypt PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria PEGylated Proteins Sales and Growth Rate (2014-2019)
    • 9.6 South Africa PEGylated Proteins Sales and Growth Rate (2014-2019)

    10 Global PEGylated Proteins Market Segment by Type

    • 10.1 Global PEGylated Proteins Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global PEGylated Proteins Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global PEGylated Proteins Revenue and Market Share by Type (2014-2019)
    • 10.2 Colony Stimulating Factors Sales Growth and Price
      • 10.2.1 Global Colony Stimulating Factors Sales Growth (2014-2019)
      • 10.2.2 Global Colony Stimulating Factors Price (2014-2019)
    • 10.3 Interferons Sales Growth and Price
      • 10.3.1 Global Interferons Sales Growth (2014-2019)
      • 10.3.2 Global Interferons Price (2014-2019)
    • 10.4 Erythropoietin (EPO) Sales Growth and Price
      • 10.4.1 Global Erythropoietin (EPO) Sales Growth (2014-2019)
      • 10.4.2 Global Erythropoietin (EPO) Price (2014-2019)
    • 10.5 Recombinant Factor Viii Sales Growth and Price
      • 10.5.1 Global Recombinant Factor Viii Sales Growth (2014-2019)
      • 10.5.2 Global Recombinant Factor Viii Price (2014-2019)
    • 10.6 Monoclonal Antibodies Sales Growth and Price
      • 10.6.1 Global Monoclonal Antibodies Sales Growth (2014-2019)
      • 10.6.2 Global Monoclonal Antibodies Price (2014-2019)
    • 10.7 Others Sales Growth and Price
      • 10.7.1 Global Others Sales Growth (2014-2019)
      • 10.7.2 Global Others Price (2014-2019)

    11 Global PEGylated Proteins Market Segment by Application

    • 11.1 Global PEGylated Proteins Sales Market Share by Application (2014-2019)
    • 11.2 Cancer Treatment Sales Growth (2014-2019)
    • 11.3 Hepatitis Sales Growth (2014-2019)
    • 11.4 Chronic Kidney Disease Sales Growth (2014-2019)
    • 11.5 Leukemia Sales Growth (2014-2019)
    • 11.6 SCID Sales Growth (2014-2019)
    • 11.7 Rheumatoid Arthritis & Crohn's Disease Sales Growth (2014-2019)
    • 11.8 Others Sales Growth (2014-2019)

    12 PEGylated Proteins Market Forecast (2019-2024)

    • 12.1 Global PEGylated Proteins Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 PEGylated Proteins Market Forecast by Regions (2019-2024)
      • 12.2.1 North America PEGylated Proteins Market Forecast (2019-2024)
      • 12.2.2 Europe PEGylated Proteins Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific PEGylated Proteins Market Forecast (2019-2024)
      • 12.2.4 South America PEGylated Proteins Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa PEGylated Proteins Market Forecast (2019-2024)
    • 12.3 PEGylated Proteins Market Forecast by Type (2019-2024)
      • 12.3.1 Global PEGylated Proteins Sales Forecast by Type (2019-2024)
      • 12.3.2 Global PEGylated Proteins Market Share Forecast by Type (2019-2024)
    • 12.4 PEGylated Proteins Market Forecast by Application (2019-2024)
      • 12.4.1 Global PEGylated Proteins Sales Forecast by Application (2019-2024)
      • 12.4.2 Global PEGylated Proteins Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on PEGylated Proteins . Industry analysis & Market Report on PEGylated Proteins is a syndicated market report, published as Global PEGylated Proteins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of PEGylated Proteins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,738.76
      4,108.14
      5,477.52
      3,205.08
      4,807.62
      6,410.16
      543,158.40
      814,737.60
      1,086,316.80
      289,953.60
      434,930.40
      579,907.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report